| 1. |
2024
Yang ML, Lin CL, Chen YC, Lu IA, Su BH, Chen YH, Liu KT, Wu, CL, Shiau AL.
Prothymosin a accelerates dengue virus-induced thrombocytopenia
. iScience
.2024
;(27)
|
|
| 2. |
2022
Yang FM,Hu MC,Weng CM,Chuang HC,Lan YT,Su BH, Heo KS, Kuo HP.
Loss of PP4 contributes to diesel exhaust particles-induced epithelial barrier integrity disruption and alarmins release
. Allergy
.2022
|
|
| 3. |
2022
Hu CY ,Su BH,Lee YC,Wang CT,Yang ML,Shen WT, Fu JT, Chen SY, Huang WY, Ou CH, Tsai YS, Kuo FC, Shiau AL, Shieh GS, Wu CL.
Interruption of the long non-coding RNA HOTAIR signaling axis ameliorates chemotherapy-induced cachexia in bladder cancer
. Journal of Biomedical Science
.2022
;(29):1-23
|
|
| 4. |
2020
Lu CS, Shiau AL, Su BH,Hsu TS ,Wang CT,Su YC,Tsai MS,Feng YH, Tseng YL, Yen YT, Wu CL, Shieh GS.
Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer
. Journal of Hematology & Oncology
.2020
;(13):1-16
|
|
| 5. |
2020
Prothymosin α activates type I collagen to develop a fibrotic placenta in gestational diabetes
. Clinical Science
.2020
|
|
| 6. |
2019
Kuo YH,Shiau AL,Tung CL,Su YC,Li CF,Su BH, 「Tsao CJ」, 「Wu CL」,「Feng YH」,「Wu P」,「」.
Expression of prothymosin α in lung cancer is associated with squamous cell carcinoma and smoking
. Oncology Letters
.2019
;(17):5740-5746
|
|
| 7. |
2019
Chen YC,Su YC,Shieh GS,Su BH,Su WC,Huang PH, 「Jiang ST」,「Shiau AL」,「Wu CL」.
Prothymosin α promotes STAT3 acetylation to induce cystogenesis in Pkd1-deficient mice
. The FASEB Journal
.2019
;(33):13051-13061
|
|
| 8. |
2017
Lu CS,Shieh GS,Wang CT,Su BH,Su YC,Chen YC, Su WC, Wu P, Yang WH, Shiau AL, Wu CL.
Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer
. Oncotarget
.2017
;(8):30844-30858
|
|
| 9. |
2015
Su BH,Tseng YL,Shieh GS,Chen YC,Wu P,Shiau AL, Wu CL.
Overexpression of prothymosin α antagonizes TGF-β signaling to promote the development of emphysema
. The Journal of Pathology
.2015
;(238):412-422
|
|
| 10. |
2015
Su BH,Shieh GS,Tseng YL,Shiau AL,Wu CL.
Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity
. Oncotarget
.2015
;(6):38308-38326
|
|
| 11. |
2015
Su YC,Ou HY,Wu HT,Wu P,Chen YC,Su BH, Shiau AL, Chang CJ, Wu CL.
Prothymosin-α Overexpression Contributes to the Development of Insulin Resistance
. The Journal of Clinical Endocrinology & Metabolism
.2015
;(100):4114-4123
|
|
| 12. |
2015
Lu CS,Hsieh JL,Lin CY,Tsai HW,Su BH,Shieh GS, Su YC, Lee CH, Chang MY, Wu CL, Shiau AL..
Potent antitumor activity of Oct4 and hypoxia dual-regulated oncolytic adenovirus against bladder cancer.
. Gene Therapy
.2015
;(22):305-315
|
|
| 13. |
2013
Su BH,Tseng YL,Shieh GS,Chen YC,Shiang YC,Wu P, Li KL, Yen TH, Shiau AL, Wu CL.
Prothymosin α Overexpression Contributes to the Development of Pulmonary Emphysema
. Nature Communications
.2013
;(4):1-13
|
|